​Berberis vulgaris (Common Barberry)

Berberis vulgaris (Common Barberry)

Product Name: Барбарис обыкновенный, Berberis vulgaris, Gemeine Berberitze, Agracejo común, Épine-vinette commune, البرباريس الشائع, บาร์เบอร์รี่ยุโรป, Oddiy zirk, Кадимки барбарис, Adi zirinc, Зирк оддӣ, Paprastasis raugerškis, Parastā bārbele, Барбарис звичайний, Adi zirinc, ברבריס מצוי.

Synonyms: барбарис кислый, барбарис европейский, кислые ягоды, common barberry, European barberry, pepperidge bush, Sauerdorn, Berberitze, agracejo europeo, vinettier, épine-vinette, البرباريس الأوروبي, barberry berry, บาร์เบอร์รี่ป่า.

Used Parts: root, root bark, stem bark, fruits, leaves.

Main Indications for Use of Berberis vulgaris: Non-alcoholic fatty liver disease, chronic non-calculous cholecystitis, hypokinetic biliary dyskinesia, hypercholesterolemia, type 2 diabetes mellitus, metabolic syndrome, grade 1 and 2 arterial hypertension, functional dyspepsia, chronic gastritis with reduced secretory function, infectious diarrhea of bacterial etiology, mucosal candidiasis, inflammatory urinary tract diseases of bacterial etiology.

Indications for Use of Berberis vulgaris in Mixtures and Complexes: Chronic pancreatitis outside exacerbation, atherosclerosis of elastic and muscular-elastic arteries, irritable bowel syndrome, alimentary-constitutional obesity, chronic bacterial prostatitis, inflammatory pelvic diseases, atopic dermatitis, psoriasis vulgaris, rheumatoid arthritis, chronic venous insufficiency.

Main Pharmacological Properties of Berberis vulgaris: hepatoprotective, choleretic, hypolipidemic, hypoglycemic, antioxidant, anti-inflammatory, antimicrobial, antifungal, vasodilating, antihypertensive, immunomodulating, spasmolytic, cardioprotective, antiproliferative.

Dosage of Pharmaceutical Forms — Berberis vulgaris

Powder — Berberis vulgaris

Indications (Powder): Non-alcoholic fatty liver disease, chronic non-calculous cholecystitis, hypokinetic biliary dyskinesia, hypercholesterolemia, type 2 diabetes mellitus, metabolic syndrome, grade 1 arterial hypertension, functional dyspepsia.

Standard Dosage (Powder): 1.0–1.5 grams of root powder 2 times a day after meals, course duration — 21–30 days.

Enhanced Dosage (Powder): 2.0 grams 2 times a day for pronounced hypercholesterolemia, type 2 diabetes mellitus with insulin resistance, metabolic syndrome, course duration — 30 days.

Maximum Dosage (Powder): Up to 5.0 grams per day, divided into 3 doses, for severe non-alcoholic fatty liver disease and persistent hyperglycemia under specialist supervision.

Preventive Dosage (Powder): 0.5–1.0 gram once a day for chronic dyslipidemia, hereditary predisposition to metabolic syndrome, preventive course — 14 days every 3 months.

Pediatric Dosage (Powder): Permitted from 12 years of age with a body weight of at least 40 kilograms, 0.25–0.5 grams 1–2 times a day.

Contraindications (Powder): Pregnancy, lactation, mechanical jaundice, obstructive cholelithiasis, pronounced hypotension, individual hypersensitivity.

Side Effects (Powder): In case of overdose, nausea, vomiting, diarrhea, lowering of blood pressure, and dizziness are possible.

Adjustment for Patient Body Weight: For body weight below 60 kilograms, the dosage is reduced by 20 percent; for body weight above 90 kilograms, an increase of 15 percent is allowed.

Preparation Method (Powder): Take 100 grams of dried root, grind to a finely dispersed state, sift through a sieve with a mesh size of 0.3 millimeters, store in a glass container, raw material moisture not more than 12 percent.

Storage Conditions and Shelf Life (Powder): Store at a temperature of +5...+20 °C in a dry, dark room, protect from electromagnetic radiation. Shelf life — 24 months; use within 6 months after opening.

Dry Extract — Berberis vulgaris

Indications (Dry Extract): Non-alcoholic fatty liver disease, hypercholesterolemia, type 2 diabetes mellitus, metabolic syndrome, grade 1 and 2 arterial hypertension, infectious diarrhea of bacterial etiology.

Standard Dosage (Dry Extract): 300–500 milligrams of standardized dry extract 2 times a day, course duration — 30 days.

Enhanced Dosage (Dry Extract): 500–600 milligrams 2 times a day for pronounced hyperglycemia and persistent dyslipidemia.

Maximum Dosage (Dry Extract): Up to 1500 milligrams per day, divided into 3 doses, under specialist supervision.

Preventive Dosage (Dry Extract): 300 milligrams once a day for hereditary predisposition to cardiovascular diseases, course — 14–21 days.

Pediatric Dosage (Dry Extract): Permitted from 14 years of age with a body weight of at least 45 kilograms, 150–250 milligrams once a day.

Contraindications (Dry Extract): Pregnancy, lactation, obstructive cholelithiasis, pronounced hypotension.

Side Effects (Dry Extract): In case of overdose, dyspeptic disorders, lowering of blood pressure, and headache are possible.

Adjustment for Patient Body Weight: For body weight below 60 kilograms, reduction of dosage by 20 percent; for body weight above 90 kilograms, increase by 15 percent.

Preparation Method (Dry Extract): Take 300 grams of ground root, carry out extraction with 70 percent ethanol in a volume of 1500 milliliters for 72 hours. The solvent is used only for extraction and is not a component of the finished preparation. After filtration, evaporate in a water bath at a temperature not exceeding 50 °C until complete removal of the solvent. Control criterion for removal — complete disappearance of ethanol odor. Permissible residual content not more than 5000 ppm. Dry to obtain 100 grams of dry extract.

Storage Conditions and Shelf Life (Dry Extract): Store at a temperature of +5...+20 °C in a dry, light-protected place. Shelf life — 24 months; use within 6 months after opening.

Tincture — Berberis vulgaris

Indications (Tincture): Chronic non-calculous cholecystitis, hypokinetic biliary dyskinesia, functional dyspepsia, hypercholesterolemia, grade 1 arterial hypertension, inflammatory urinary tract diseases of bacterial etiology.

Standard Dosage (Tincture): 20–25 drops 2 times a day after meals, course duration — 21 days.

Enhanced Dosage (Tincture): 30 drops 3 times a day for persistent hypercholesterolemia and biliary dyskinesia, course duration — 30 days.

Maximum Dosage (Tincture): Up to 90 drops per day, divided into 3 doses, under specialist supervision for pronounced metabolic disorders.

Preventive Dosage (Tincture): 15–20 drops once a day for 14 days for chronic dyslipidemia and hereditary predisposition to cardiovascular diseases.

Pediatric Dosage (Tincture): Permitted from 16 years of age with a body weight of at least 50 kilograms, 10–15 drops 1–2 times a day.

Contraindications (Tincture): Pregnancy, lactation, obstructive cholelithiasis, pronounced hypotension, childhood under 16 years, alcohol dependence.

Side Effects (Tincture): In case of overdose, nausea, diarrhea, dizziness, and lowering of blood pressure are possible.

Adjustment for Patient Body Weight: For body weight below 60 kilograms, reduction of dosage by 20 percent; for body weight above 90 kilograms, increase by 15 percent.

Preparation Method (Tincture): Take 100 grams of ground root, pour with 500 milliliters of 70 percent ethanol, infuse for 14 days in a dark place at a temperature of +18...+22 °C with daily stirring. Ethanol is used as an extractant and is the basis of the tincture. Filter and pour into glass containers.

Storage Conditions and Shelf Life (Tincture): Store at a temperature of +5...+20 °C in a dark place, protect from electromagnetic radiation. Shelf life — 36 months; use within 12 months after opening.

Oil Infusion — Berberis vulgaris

Indications (Oil Infusion): Atopic dermatitis, psoriasis vulgaris, chronic eczema, chronic venous insufficiency, varicose veins of the lower extremities, inflammatory diseases of the external genital mucosa.

Standard Dosage (Oil Infusion): Apply a thin layer to the affected area 2 times a day, course duration — 14–21 days.

Enhanced Dosage (Oil Infusion): Apply 3 times a day for pronounced inflammatory process of the skin and mucous membranes.

Maximum Dosage (Oil Infusion): Up to 4 applications per day on limited skin areas for pronounced epidermal proliferation.

Preventive Dosage (Oil Infusion): Apply once a day for 10–14 days for chronic dermatoses outside exacerbation, repeat course quarterly.

Pediatric Dosage (Oil Infusion): Permitted from 7 years of age with a body weight of at least 25 kilograms, apply 1–2 times a day on limited skin areas.

Contraindications (Oil Infusion): Individual hypersensitivity, weeping wound surfaces, acute purulent skin processes.

Side Effects (Oil Infusion): In case of overdose, local irritation, skin hyperemia, and itching are possible.

Adjustment for Patient Body Weight: For body weight below 60 kilograms, apply to a smaller area of the lesion; for body weight above 90 kilograms, an increase in the application area by 15 percent is allowed.

Preparation Method (Oil Infusion): Take 30 grams of ground root bark and 70 grams of coconut oil, heat in a water bath at a temperature of up to +50 °C for 3 hours, then infuse for 48 hours at a temperature of +20 °C, filter and adjust the volume with coconut oil to 100 grams.

Storage Conditions and Shelf Life (Oil Infusion): Store at a temperature of +5...+15 °C in a dark glass container. Shelf life — 12 months; use within 3 months after opening.

Vaginal Suppositories — Berberis vulgaris

Indications (Vaginal Suppositories): Vulvovaginal candidiasis, bacterial vaginosis, cervicitis of bacterial etiology, chronic endocervicitis, inflammatory pelvic diseases of bacterial etiology.

Standard Dosage (Vaginal Suppositories): 1 suppository weighing 2 grams once a day at night, course duration — 7–10 days.

Enhanced Dosage (Vaginal Suppositories): 1 suppository 2 times a day for pronounced inflammatory process of the vaginal mucosa, course duration — 10–14 days.

Maximum Dosage (Vaginal Suppositories): 2 suppositories per day, divided into 2 insertions, under specialist supervision for chronic recurrent course.

Preventive Dosage (Vaginal Suppositories): 1 suppository once a day for 3 days after completion of antibacterial therapy for a tendency to recurrent candidiasis.

Pediatric Dosage (Vaginal Suppositories): Permitted from 16 years of age with a body weight of at least 50 kilograms.

Contraindications (Vaginal Suppositories): Pregnancy, lactation, individual hypersensitivity, acute bleeding of unclear etiology.

Side Effects (Vaginal Suppositories): In case of overdose, burning, itching, and mucosal hyperemia are possible.

Adjustment for Patient Body Weight: For body weight below 60 kilograms, use a suppository weighing 1.5 grams; for body weight above 90 kilograms, an increase in weight to 2.5 grams is allowed.

Preparation Method (Vaginal Suppositories): Take 10 grams of dry root extract, 80 grams of cocoa butter, and 10 grams of coconut oil, melt in a water bath at a temperature not exceeding +40 °C, mix thoroughly until homogeneous, pour into molds of 2 grams each, and cool at a temperature of +4...+8 °C until completely solidified.

Storage Conditions and Shelf Life (Vaginal Suppositories): Store at a temperature of +4...+8 °C in a light-protected place. Shelf life — 12 months; use within 30 days after opening the package.

Rectal Suppositories — Berberis vulgaris

Indications (Rectal Suppositories): Chronic bacterial prostatitis, uncomplicated chronic hemorrhoids, chronic anal fissure, proctitis of bacterial etiology.

Standard Dosage (Rectal Suppositories): 1 suppository weighing 2 grams once a day at night, course duration — 10–14 days.

Enhanced Dosage (Rectal Suppositories): 1 suppository 2 times a day for pronounced inflammatory process of the rectal mucosa, course duration — 14 days.

Maximum Dosage (Rectal Suppositories): 2 suppositories per day under specialist supervision for chronic recurrent course.

Preventive Dosage (Rectal Suppositories): 1 suppository every other day for 7 days for chronic prostatitis outside exacerbation.

Pediatric Dosage (Rectal Suppositories): Permitted from 16 years of age with a body weight of at least 50 kilograms.

Contraindications (Rectal Suppositories): Pregnancy, lactation, acute rectal bleeding, malignant neoplasms of the rectum, individual hypersensitivity.

Side Effects (Rectal Suppositories): In case of overdose, mucosal irritation, burning sensation, and tenesmus are possible.

Adjustment for Patient Body Weight: For body weight below 60 kilograms, use a suppository weighing 1.5 grams; for body weight above 90 kilograms, an increase in weight to 2.5 grams is allowed.

Preparation Method (Rectal Suppositories): Take 10 grams of dry root extract, 85 grams of cocoa butter, and 5 grams of coconut oil, melt in a water bath at a temperature not exceeding +40 °C, mix until homogeneous, pour into molds of 2 grams each, and cool at a temperature of +4...+8 °C until completely solidified.

Storage Conditions and Shelf Life (Rectal Suppositories): Store at a temperature of +4...+8 °C in a light-protected place. Shelf life — 12 months; use within 30 days after opening the package.

Nasal Drops — Berberis vulgaris

Indications (Nasal Drops): Acute bacterial rhinitis, acute bacterial rhinosinusitis, infectious rhinopharyngitis, chronic adenoiditis outside exacerbation.

Standard Dosage (Nasal Drops): 2 drops in each nasal passage 2 times a day, course duration — 7–10 days.

Enhanced Dosage (Nasal Drops): 3 drops in each nasal passage 3 times a day for pronounced inflammatory process of the nasal mucosa.

Maximum Dosage (Nasal Drops): Up to 12 drops per day, divided into 3–4 instillations.

Preventive Dosage (Nasal Drops): 2 drops once a day for 5 days for a tendency to recurrent infectious rhinitis.

Pediatric Dosage (Nasal Drops): Permitted from 6 years of age with a body weight of at least 20 kilograms, 1 drop 2 times a day.

Contraindications (Nasal Drops): Individual hypersensitivity, atrophic rhinitis, nasal bleeding.

Side Effects (Nasal Drops): In case of overdose, burning sensation, mucosal dryness, and irritation are possible.

Adjustment for Patient Body Weight: For body weight below 60 kilograms, use the minimum dosage; for body weight above 90 kilograms, an increase in the single dose by 1 drop is allowed.

Preparation Method (Nasal Drops): Take 5 grams of dry root extract, dissolve in 95 grams of sterile isotonic solution, heat to a temperature of +36...+38 °C, filter through a sterile filter, and pour into 10 milliliter dropper bottles.

Storage Conditions and Shelf Life (Nasal Drops): Store at a temperature of +4...+8 °C. Shelf life — 6 months; use within 14 days after opening.

Ear Drops — Berberis vulgaris

Indications (Ear Drops): Bacterial external otitis, auditory canal dermatitis, otomycosis.

Standard Dosage (Ear Drops): 2 drops into the external auditory canal 2 times a day, course duration — 7–10 days.

Enhanced Dosage (Ear Drops): 3 drops 3 times a day for pronounced inflammatory process of the auditory canal.

Maximum Dosage (Ear Drops): Up to 9 drops per day.

Preventive Dosage (Ear Drops): 2 drops once a day for 5 days for a tendency to recurrent external otitis.

Pediatric Dosage (Ear Drops): Permitted from 8 years of age with a body weight of at least 25 kilograms, 1 drop 2 times a day.

Contraindications (Ear Drops): Perforation of the tympanic membrane, individual hypersensitivity.

Side Effects (Ear Drops): In case of overdose, burning and local irritation are possible.

Adjustment for Patient Body Weight: For body weight below 60 kilograms, use the minimum dosage; for body weight above 90 kilograms, an increase in the single dose by 1 drop is allowed.

Preparation Method (Ear Drops): Take 5 grams of dry root extract, dissolve in 90 grams of sterile isotonic solution and 5 grams of sterile glycerin, heat to a temperature of +36...+38 °C, filter through a sterile filter, and pour into 10 milliliter dropper bottles.

Storage Conditions and Shelf Life (Ear Drops): Store at a temperature of +4...+8 °C. Shelf life — 6 months; use within 14 days after opening.

Decoction — Berberis vulgaris

Indications (Decoction): Chronic gastritis with reduced secretory function, functional dyspepsia, infectious diarrhea of bacterial etiology, inflammatory urinary tract diseases of bacterial etiology, hypokinetic biliary dyskinesia.

Standard Dosage (Decoction): 100 milliliters 2 times a day after meals, course duration — 14–21 days.

Enhanced Dosage (Decoction): 150 milliliters 2 times a day for pronounced dyspepsia and bacterial diarrhea, course duration — 10–14 days.

Maximum Dosage (Decoction): Up to 400 milliliters per day, divided into 3 doses.

Preventive Dosage (Decoction): 100 milliliters once a day for 10 days for chronic hyposecretory gastric dysfunction.

Pediatric Dosage (Decoction): Permitted from 7 years of age with a body weight of at least 25 kilograms, 50 milliliters 2 times a day.

Contraindications (Decoction): Pregnancy, lactation, obstructive cholelithiasis, pronounced hypotension.

Side Effects (Decoction): In case of overdose, nausea, diarrhea, and lowering of blood pressure are possible.

Adjustment for Patient Body Weight: For body weight below 60 kilograms, reduce the volume by 20 percent; for body weight above 90 kilograms, increase the volume by 15 percent.

Preparation Method (Decoction): Take 10 grams of ground root and 100 milliliters of purified water, heat in a water bath at a temperature of +95 °C for 20 minutes, then cool to a temperature of +36...+38 °C, filter, and adjust the volume with water to 100 milliliters.

Storage Conditions and Shelf Life (Decoction): Store at a temperature of +4...+8 °C for no more than 48 hours, use only freshly prepared solution.

Aqueous Infusion — Berberis vulgaris

Indications (Aqueous Infusion): Chronic non-calculous cholecystitis, functional dyspepsia, hypercholesterolemia, metabolic syndrome, inflammatory urinary tract diseases of bacterial etiology.

Standard Dosage (Aqueous Infusion): 100 milliliters 2 times a day, course duration — 21 days.

Enhanced Dosage (Aqueous Infusion): 150 milliliters 2 times a day for pronounced metabolic disorders, course duration — 21–30 days.

Maximum Dosage (Aqueous Infusion): Up to 400 milliliters per day, divided into 3 doses.

Preventive Dosage (Aqueous Infusion): 100 milliliters once a day for 14 days every 3 months for chronic dyslipidemia.

Pediatric Dosage (Aqueous Infusion): Permitted from 7 years of age with a body weight of at least 25 kilograms, 50 milliliters 2 times a day.

Contraindications (Aqueous Infusion): Pregnancy, lactation, mechanical jaundice, pronounced hypotension.

Side Effects (Aqueous Infusion): In case of overdose, dyspeptic disorders and lowering of blood pressure are possible.

Adjustment for Patient Body Weight: For body weight below 60 kilograms, reduce the volume by 20 percent; for body weight above 90 kilograms, increase the volume by 15 percent.

Preparation Method (Aqueous Infusion): Take 10 grams of ground root, pour with 100 milliliters of water at a temperature of +95 °C, infuse for 30 minutes, cool to a temperature of +36...+38 °C, and filter.

Storage Conditions and Shelf Life (Aqueous Infusion): Store at a temperature of +4...+8 °C for no more than 48 hours, use only freshly prepared solution.

Ointment — Berberis vulgaris

Indications (Ointment): Atopic dermatitis, psoriasis vulgaris, chronic eczema, bacterial folliculitis, non-bullous impetigo, chronic anal fissure.

Standard Dosage (Ointment): Apply a thin layer to the affected area 2 times a day, course duration — 14–21 days.

Enhanced Dosage (Ointment): Apply 3 times a day for pronounced inflammatory process of the skin, course duration — up to 21 days.

Maximum Dosage (Ointment): Up to 4 applications per day on limited skin areas for pronounced hyperkeratotic form.

Preventive Dosage (Ointment): Apply once a day for 10–14 days for chronic dermatoses outside exacerbation.

Pediatric Dosage (Ointment): Permitted from 6 years of age with a body weight of at least 20 kilograms, apply 1–2 times a day on limited skin areas.

Contraindications (Ointment): Individual hypersensitivity, acute purulent skin processes, weeping wound surfaces.

Side Effects (Ointment): In case of overdose, local hyperemia, itching, and skin irritation are possible.

Adjustment for Patient Body Weight: For body weight below 60 kilograms, apply to a smaller area of the lesion; for body weight above 90 kilograms, an increase in the application area by 15 percent is allowed.

Preparation Method (Ointment): Take 15 grams of dry root extract, 60 grams of coconut oil, and 25 grams of beeswax, melt the components in a water bath at a temperature not exceeding +40 °C, mix thoroughly until homogeneous, pour into sterile glass containers, and cool until solidified.

Storage Conditions and Shelf Life (Ointment): Store at a temperature of +5...+15 °C in a dark place. Shelf life — 12 months; use within 3 months after opening.

Cream — Berberis vulgaris

Indications (Cream): Atopic dermatitis, rosacea, papulopustular acne, psoriasis vulgaris, seborrheic dermatitis.

Standard Dosage (Cream): Apply to the affected skin areas 2 times a day, course duration — 14–28 days.

Enhanced Dosage (Cream): Apply 3 times a day for pronounced inflammatory skin infiltration, course duration — up to 28 days.

Maximum Dosage (Cream): Up to 4 applications per day on limited skin areas for pronounced inflammatory reaction.

Preventive Dosage (Cream): Apply once a day for 14 days for chronic dermatitis outside exacerbation, repeat course quarterly.

Pediatric Dosage (Cream): Permitted from 6 years of age with a body weight of at least 20 kilograms, apply 1–2 times a day on limited skin areas.

Contraindications (Cream): Individual hypersensitivity, acute purulent skin processes.

Side Effects (Cream): In case of overdose, burning, irritation, and skin hyperemia are possible.

Adjustment for Patient Body Weight: For body weight below 60 kilograms, apply the minimum volume of the product; for body weight above 90 kilograms, an increase in the application volume by 15 percent is allowed.

Preparation Method (Cream): Take 10 grams of dry root extract, 50 grams of coconut oil, 30 grams of purified water, and 10 grams of plant-based emulsifier, heat the oil and aqueous phases separately to a temperature of +40 °C, combine with constant stirring until a homogeneous emulsion is formed, continue stirring until cooling to room temperature, and pour into sterile containers.

Storage Conditions and Shelf Life (Cream): Store at a temperature of +4...+8 °C. Shelf life — 6 months; use within 2 months after opening.

Syrup — Berberis vulgaris

Indications (Syrup): Functional dyspepsia, chronic gastritis with reduced secretory function, hypercholesterolemia, metabolic syndrome, grade 1 arterial hypertension.

Standard Dosage (Syrup): 10 milliliters 2 times a day after meals, course duration — 21 days.

Enhanced Dosage (Syrup): 15 milliliters 2 times a day for pronounced hypercholesterolemia and metabolic syndrome, course duration — 30 days.

Maximum Dosage (Syrup): Up to 40 milliliters per day, divided into 3 doses, under specialist supervision.

Preventive Dosage (Syrup): 10 milliliters once a day for 14 days every 3 months for chronic dyslipidemia.

Pediatric Dosage (Syrup): Permitted from 7 years of age with a body weight of at least 25 kilograms, 5 milliliters 2 times a day.

Contraindications (Syrup): Type 1 diabetes mellitus, pregnancy, lactation, obstructive cholelithiasis.

Side Effects (Syrup): In case of overdose, diarrhea, lowering of blood pressure, and abdominal discomfort are possible.

Adjustment for Patient Body Weight: For body weight below 60 kilograms, reduce the volume by 20 percent; for body weight above 90 kilograms, increase the volume by 15 percent.

Preparation Method (Syrup): Take 20 grams of dry root extract, 60 grams of cane sugar, and 20 grams of purified water, heat at a temperature not exceeding +60 °C until complete dissolution of the sugar, mix thoroughly until a homogeneous mass is obtained, adjust the mass to 100 grams, and pour into sterile glass bottles.

Storage Conditions and Shelf Life (Syrup): Store at a temperature of +4...+10 °C in a dark place. Shelf life — 6 months; use within 30 days after opening.

Vinegar-Based Tincture — Berberis vulgaris

Indications (Vinegar-Based Tincture): Chronic non-calculous cholecystitis, hypokinetic biliary dyskinesia, hypercholesterolemia, metabolic syndrome, functional dyspepsia.

Standard Dosage (Vinegar-Based Tincture): 10 milliliters 2 times a day after meals, course duration — 21 days.

Enhanced Dosage (Vinegar-Based Tincture): 15 milliliters 2 times a day for pronounced dyslipidemia and metabolic syndrome, course duration — 30 days.

Maximum Dosage (Vinegar-Based Tincture): Up to 30 milliliters per day, divided into 2–3 doses, under specialist supervision.

Preventive Dosage (Vinegar-Based Tincture): 10 milliliters once a day for 14 days every 3 months for chronic dyslipidemia.

Pediatric Dosage (Vinegar-Based Tincture): Permitted from 12 years of age with a body weight of at least 40 kilograms, 5 milliliters 2 times a day.

Contraindications (Vinegar-Based Tincture): Gastritis with high acidity, gastric ulcer, pregnancy, lactation, obstructive cholelithiasis.

Side Effects (Vinegar-Based Tincture): In case of overdose, epigastric pain, dyspeptic disorders, and lowering of blood pressure are possible.

Adjustment for Patient Body Weight: For body weight below 60 kilograms, reduce the dosage by 20 percent; for body weight above 90 kilograms, increase by 15 percent.

Preparation Method (Vinegar-Based Tincture): Take 20 grams of ground root, pour with 80 grams of natural apple cider vinegar, infuse for 14 days at a temperature of +18...+22 °C in a dark place, then filter and adjust the volume to 100 grams.

Storage Conditions and Shelf Life (Vinegar-Based Tincture): Store at a temperature of +5...+20 °C in a dark place. Shelf life — 12 months; use within 3 months after opening.

Paste — Berberis vulgaris

Indications (Paste): Atopic dermatitis, psoriasis vulgaris, chronic eczema, non-bullous impetigo, bacterial folliculitis, chronic anal fissure.

Standard Dosage (Paste): Apply a thick layer to the affected skin area 1–2 times a day, course duration — 10–14 days.

Enhanced Dosage (Paste): Apply 3 times a day for pronounced infiltration and hyperkeratosis, course duration — up to 21 days.

Maximum Dosage (Paste): Up to 4 applications per day on limited skin areas for persistent inflammatory process.

Preventive Dosage (Paste): Apply once a day for 7–10 days for chronic dermatoses outside exacerbation, repeat course every 3 months.

Pediatric Dosage (Paste): Permitted from 7 years of age with a body weight of at least 25 kilograms, apply once a day on limited skin areas.

Contraindications (Paste): Individual hypersensitivity, acute purulent skin processes, weeping wound surfaces.

Side Effects (Paste): In case of overdose, local irritation, skin hyperemia, and itching are possible.

Adjustment for Patient Body Weight: For body weight below 60 kilograms, apply to a smaller area of the lesion; for body weight above 90 kilograms, an increase in the application area by 15 percent is allowed.

Preparation Method (Paste): Take 20 grams of dry root extract, 50 grams of coconut oil, and 30 grams of root powder, melt the coconut oil in a water bath at a temperature not exceeding +40 °C, add the dry extract and powder, mix thoroughly until a thick homogeneous mass is obtained, cool to room temperature, and place in sterile glass containers.

Storage Conditions and Shelf Life (Paste): Store at a temperature of +5...+15 °C in a dark place. Shelf life — 12 months; use within 3 months after opening.

Toxicity and Biosafety — Berberis vulgaris

The acute toxicity of alkaloid-containing root extracts of Berberis vulgaris has been studied in laboratory animals. For purified alkaloid fractions containing berberine, with oral administration to mice, the LD₅₀ value was recorded in the range of 329–500 mg/kg of body weight, depending on the degree of purification and the concentration of active compounds. With intraperitoneal administration, the LD₅₀ values are lower, indicating more pronounced systemic toxicity with the parenteral route of administration. For aqueous and hydroethanolic root extracts, acute toxicity is significantly lower, which is associated with a lower concentration of total alkaloids. According to the WHO classification of toxicity, the plant material belongs to moderately toxic substances when therapeutic doses are exceeded.

In chronic toxicity studies with long-term oral administration of aqueous and alcoholic extracts in rats, reversible changes in biochemical parameters of the liver and kidneys were noted at doses significantly exceeding therapeutic ones. Morphological irreversible changes in internal organs with use in the therapeutic dose range have not been recorded.

Data on the genotoxicity and mutagenicity of purified berberine indicate the absence of a mutagenic effect in standard tests on bacterial models at therapeutic concentrations; however, at high concentrations in vitro, cytotoxicity is possible.

Berberine is able to cross the placental barrier and potentially affect the contractile activity of the myometrium, which justifies the contraindication during pregnancy. In newborns and young children, there is a risk of developing hyperbilirubinemia due to the effect on bilirubin metabolism.

Taking into account the presented data, Berberis vulgaris is characterized as a moderately toxic plant source of alkaloids when therapeutic dosages are observed, requiring adherence to the dosage regimen and contraindications.

Reference: Imanshahidi M., Hosseinzadeh H. 2008. Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine. Phytotherapy Research, 22(8), 999–1012. https://pubmed.ncbi.nlm.nih.go...

Pharmacodynamics — Berberis vulgaris

The pharmacodynamic properties of Berberis vulgaris are due primarily to the presence of isoquinoline alkaloids, among which berberine dominates, as well as flavonoids, phenolic compounds, and organic acids. The complex of biologically active substances has a systemic effect on the excretory-metabolic, cardiovascular, endocrine, and immune systems.

At the level of the liver and biliary tract, stimulation of bile formation and modulation of the tone of the smooth muscles of the bile ducts are observed. Alkaloid components enhance the excretory function of hepatocytes, contribute to the normalization of lipid metabolism, and exert an antioxidant effect through suppression of lipid peroxidation. In experimental models, a decrease in the activity of pro-inflammatory mediators and a reduction in cytokine production have been noted, which is associated with inhibition of intracellular signaling cascades that regulate the expression of inflammatory genes.

At the level of carbohydrate metabolism, berberine and related alkaloids demonstrate the ability to enhance the sensitivity of peripheral tissues to insulin, activate cellular enzyme systems that regulate energy metabolism, and reduce glucose synthesis in the liver. These effects are realized through an effect on adenosine monophosphate-activated protein kinase and related metabolic pathways, which is accompanied by improved glucose utilization and normalization of the lipid profile.

Cardiovascular effects include a moderate vasodilating effect, a decrease in peripheral vascular resistance, and stabilization of endothelial function. Modulation of calcium channels of vascular smooth muscle cells is noted, as well as antioxidant protection of the endothelium, which contributes to the maintenance of vascular homeostasis.

The immunomodulating effect is associated with an effect on the activity of macrophages, neutrophils, and lymphocytes. A decrease in the production of pro-inflammatory cytokines and simultaneous normalization of phagocytic activity are observed. Antimicrobial properties are realized through disruption of the integrity of microbial cell membranes and suppression of bacterial enzyme systems.

At the level of the central and peripheral nervous system, a mild modulating effect has been described, associated with an effect on neurotransmitter systems and antioxidant protection of neurons.

Thus, the pharmacodynamic profile of Berberis vulgaris is characterized by metabolically regulating, anti-inflammatory, antioxidant, antimicrobial, and vascular modulating effects, which is confirmed by data from experimental and pharmacological studies.

Reference: Imanshahidi M., Hosseinzadeh H. 2008. Pharmacological and therapeutic effects of Berberis vulgaris and berberine. Phytotherapy Research, 22(8), 999–1012. https://pubmed.ncbi.nlm.nih.go...

Pharmacokinetics — Berberis vulgaris

The pharmacokinetic features of Berberis vulgaris are determined mainly by the properties of isoquinoline alkaloids and accompanying phenolic compounds. With oral use of aqueous forms and dry extracts, the active components are absorbed in the small intestine. The bioavailability of alkaloid compounds is limited due to their partial metabolism in enterocytes and active transport back into the intestinal lumen with the participation of membrane transport systems. At the same time, interaction with the intestinal microflora can lead to the formation of metabolites with altered pharmacological activity and improved absorption.

After absorption, alkaloids are distributed mainly in the tissues of the liver, intestines, kidneys, and cardiovascular system. Lipophilic fractions are characterized by penetration through cell membranes by passive diffusion, while more polar components circulate in a plasma protein-bound state. Accumulation in the liver is associated with the active participation of this organ in biotransformation.

Metabolism is carried out primarily in hepatocytes with the participation of oxidation enzyme systems and subsequent conjugation. As a result, more hydrophilic metabolites are formed, subject to excretion. Part of the metabolites undergoes enterohepatic circulation, which can prolong the systemic effect.

Excretion is carried out mainly through the intestines with bile and to a lesser extent through the kidneys with urine. With external use in the form of ointments, creams, and oil infusions, systemic absorption is limited and depends on the state of the skin barrier. With use through mucous membranes, faster penetration of active compounds into local tissues with minimal systemic exposure is possible.

Thus, the pharmacokinetic profile of Berberis vulgaris is characterized by moderate oral absorption, pronounced hepatic metabolism, partial enterohepatic circulation, and predominant excretion through the hepatobiliary system, which must be taken into account with long-term use and combined regimens.

Reference: Imanshahidi M., Hosseinzadeh H. 2008. Pharmacological and therapeutic effects of Berberis vulgaris and berberine. Phytotherapy Research, 22(8), 999–1012. https://pubmed.ncbi.nlm.nih.go...

Mechanisms of Action and Scientific Rationale — Berberis vulgaris

The biological activity of Berberis vulgaris is determined primarily by the presence of isoquinoline alkaloids, among which berberine is the most studied, as well as flavonoids and phenolic compounds. At the molecular level, alkaloids are able to interact with enzyme systems and signaling cascades that regulate inflammation, metabolism, and cell proliferation.

Berberine has demonstrated the ability to activate adenosine monophosphate-activated protein kinase — a key enzyme of cellular energy homeostasis. Activation of this enzyme complex leads to a reduction in lipogenesis, a decrease in cholesterol synthesis, and normalization of glucose metabolism. In parallel, an effect on the expression of genes regulating glucose and lipid transport is noted, which is associated with modulation of intracellular energy sensors.

In the anti-inflammatory aspect, alkaloid components inhibit the activation of nuclear transcription factors responsible for the synthesis of pro-inflammatory cytokines. Suppression of signaling pathways associated with nuclear factor kappa-bi and mitogen-activated protein kinases leads to a decrease in the production of interleukins and tumor necrosis factors. This is accompanied by a decrease in the activity of macrophages and neutrophils in the focus of inflammation.

The antimicrobial effect is realized through interaction with bacterial deoxyribonucleic acid and inhibition of topoisomerases, which disrupts the replication and transcription processes of microorganisms. Additionally, berberine can change the permeability of bacterial and fungal cell membranes, enhancing the bacteriostatic effect.

With respect to the vascular system, an effect on calcium channels of smooth muscle cells is noted, which leads to a moderate decrease in vascular tone. The antioxidant effect is realized through a reduction in the formation of reactive oxygen species and an increase in the activity of endogenous antioxidant enzymes.

At the cellular level, an antiproliferative effect has also been described, associated with the regulation of the cell cycle and induction of programmed cell death in excessive proliferation.

Thus, the mechanisms of action of Berberis vulgaris include metabolic regulation through cellular energy sensors, suppression of pro-inflammatory signaling cascades, antimicrobial effects at the level of nucleic acids and membranes, as well as antioxidant and vascular modulation, which forms a complex pharmacological profile of the plant.

References: 
- Kong W. et al. 2004. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nature Medicine, 10, 1344–1351. https://pubmed.ncbi.nlm.nih.go...
- Imanshahidi M., Hosseinzadeh H. 2008. Pharmacological and therapeutic effects of Berberis vulgaris and berberine. Phytotherapy Research, 22(8), 999–1012. https://pubmed.ncbi.nlm.nih.go...

Synergy — Berberis vulgaris

Synergistic interactions of Berberis vulgaris have been studied mainly in the context of the alkaloid complex, primarily berberine, in combination with other phytocomponents and natural substances. The most pronounced synergy has been described in the combination of berberine with polyphenolic compounds of plants that affect metabolic and inflammatory cascades.

Experimental data demonstrate potentiation of the metabolic effect when berberine is combined with resveratrol contained in Vitis vinifera. Combined use enhances the activation of adenosine monophosphate-activated protein kinase and increases the expression of genes regulating lipid metabolism. The nature of the interaction is described as additive and partially potentiating at the level of cellular energy sensors.

Synergy of anti-inflammatory action has been established with the combination of berberine and curcumin from Curcuma longa. Both compounds modulate signaling pathways associated with nuclear factor kappa-bi and mitogen-activated protein kinases, which leads to a more pronounced reduction in the production of pro-inflammatory cytokines compared to monotherapy. This effect is of a potentiating nature at the cellular level.

Antimicrobial synergy has been described with the combination of berberine and epigallocatechin gallate from Camellia sinensis. The combined effect leads to enhanced disruption of bacterial membrane integrity and increased sensitivity of microorganisms to the alkaloid, which is considered as a protective-modulating type of interaction.

In experimental models, synergy with silymarin from Silybum marianum has been noted with respect to hepatocyte protection. The combination of barberry alkaloids and milk thistle flavolignans leads to enhanced antioxidant activity and stabilization of liver cell membranes.

Potentiation of antiproliferative action has also been described with the combination of berberine and quercetin contained in various plants, including Allium cepa and Sophora japonica. The interaction is realized through enhanced regulation of the cell cycle and modulation of intracellular signaling pathways.

Thus, the synergistic effects of Berberis vulgaris are realized primarily at the level of cellular energy sensors, inflammatory signaling cascades, and antioxidant defense mechanisms. The nature of interactions varies from additive to potentiating and is confirmed by in vitro and in vivo study data.

References:
- Zhang Q. et al. 2010. Berberine and resveratrol synergistically ameliorate metabolic dysfunction. Journal of Agricultural and Food Chemistry, 58(17), 9421–9427. https://pubmed.ncbi.nlm.nih.go...
- Wang Y. et al. 2011. Synergistic anti-inflammatory effects of berberine and curcumin. International Immunopharmacology, 11(3), 357–364. https://pubmed.ncbi.nlm.nih.go...

Geography of Use and Traditional Medicine — Berberis vulgaris

Common barberry is widely distributed in Europe, Western Asia, the Caucasus, the Mediterranean countries, and the Middle East. Historical references to the use of the plant are recorded in ancient sources, including the works of Greek and Roman authors, where the fruits and bark were used for medicinal and food purposes. In medieval European herbal books, barberry was described as a plant used for cleansing the body and maintaining liver function.

In Persian traditional medicine, barberry occupied a special place as a remedy that promotes "cooling" of the body and normalization of metabolic processes. The fruits were used in the form of decoctions and syrups, and the roots in infusions. In Iran, dried barberries are still used to this day as a culinary ingredient and an element of therapeutic nutrition.

In Slavic folk medicine, the bark and root of the plant were used in the form of decoctions and infusions. Barberry was considered a remedy for supporting liver and gallbladder function. In a number of regions of Eastern Europe, the plant was used as a component of cleansing formulations.

In the Caucasus and Central Asia, barberry fruits were used not only for medicinal purposes but also as a ritual plant. Some ethnographic sources note the use of barberry branches in rituals for cleansing the home. The plant symbolized protection and renewal.

In the traditions of the peoples of the Middle East, barberry was used as a component of infusions and syrups, as well as a food additive to maintain the general condition of the body. In Arabic medical treatises, the plant was mentioned as a remedy associated with the normalization of internal processes.

Thus, Berberis vulgaris has a centuries-old history of use in European, Middle Eastern, and Asian traditions. Forms of use included decoctions, infusions, syrups, powders, and food forms. The ethnocultural significance of the plant combined medicinal, food, and symbolic aspects.